• Home

  • Documents

  •  · Coryol 6.25 mg, Sandoz GmbH, Alemania Glivec 400 MG PRODUCTO INNOVADOR, Novartis Pharma AG, ......
7

 · Coryol 6.25 mg, Sandoz GmbH, Alemania Glivec 400 MG PRODUCTO INNOVADOR, Novartis Pharma AG, ... S.A de C.V. México Albumina Humana 200g/L Kedrion Spa. Italia Beriate 500 CSI-

Embed Size (px)

Citation preview

Page 1:  · Coryol 6.25 mg, Sandoz GmbH, Alemania Glivec 400 MG PRODUCTO INNOVADOR, Novartis Pharma AG, ... S.A de C.V. México Albumina Humana 200g/L Kedrion Spa. Italia Beriate 500 CSI-
Page 2:  · Coryol 6.25 mg, Sandoz GmbH, Alemania Glivec 400 MG PRODUCTO INNOVADOR, Novartis Pharma AG, ... S.A de C.V. México Albumina Humana 200g/L Kedrion Spa. Italia Beriate 500 CSI-
Page 3:  · Coryol 6.25 mg, Sandoz GmbH, Alemania Glivec 400 MG PRODUCTO INNOVADOR, Novartis Pharma AG, ... S.A de C.V. México Albumina Humana 200g/L Kedrion Spa. Italia Beriate 500 CSI-
Page 4:  · Coryol 6.25 mg, Sandoz GmbH, Alemania Glivec 400 MG PRODUCTO INNOVADOR, Novartis Pharma AG, ... S.A de C.V. México Albumina Humana 200g/L Kedrion Spa. Italia Beriate 500 CSI-
Page 5:  · Coryol 6.25 mg, Sandoz GmbH, Alemania Glivec 400 MG PRODUCTO INNOVADOR, Novartis Pharma AG, ... S.A de C.V. México Albumina Humana 200g/L Kedrion Spa. Italia Beriate 500 CSI-
Page 6:  · Coryol 6.25 mg, Sandoz GmbH, Alemania Glivec 400 MG PRODUCTO INNOVADOR, Novartis Pharma AG, ... S.A de C.V. México Albumina Humana 200g/L Kedrion Spa. Italia Beriate 500 CSI-
Page 7:  · Coryol 6.25 mg, Sandoz GmbH, Alemania Glivec 400 MG PRODUCTO INNOVADOR, Novartis Pharma AG, ... S.A de C.V. México Albumina Humana 200g/L Kedrion Spa. Italia Beriate 500 CSI-

Shamnad Basheer Glivec Patent Saga

Shamnad Basheer Glivec Patent Saga

Documents
The Glivec Precedent

The Glivec Precedent

Documents
Kedrion a #ToscanacheInnova

Kedrion a #ToscanacheInnova

Data & Analytics
ANNUAL REPORT - Kedrion 16...market, becoming to all effects a global player, capable of challenging the leaders of the highly concentrated plasma-de-rived industry. Kedrion took on

ANNUAL REPORT - Kedrion 16...market, becoming to all effects a global player, capable of challenging the leaders of the highly concentrated plasma-de-rived industry. Kedrion took on

Documents
onac.org.co · 2019. 11. 20. · 0,001 5 mg 0.0023 mg 0,0036 mg 0,0047 mg 0,0042 mg 0,0019 mg 00032 mg 0,0047 mg 0,0042 mg 0,0089 mg 0.013 mg 0,029 mg 0.049 mg 0,073 mg 0.21 mg 0,43

onac.org.co · 2019. 11. 20. · 0,001 5 mg 0.0023 mg 0,0036 mg 0,0047 mg 0,0042 mg 0,0019 mg 00032 mg 0,0047 mg 0,0042 mg 0,0089 mg 0.013 mg 0,029 mg 0.049 mg 0,073 mg 0.21 mg 0,43

Documents
2 QUALITATIVE AND QUANTITATIVE COMPOSITION · 2020-01-17 · resume Glivec at reduced dose of 400 mg. ANC = absolute neutrophil count aoccurring after at least 1 month of treatment

2 QUALITATIVE AND QUANTITATIVE COMPOSITION · 2020-01-17 · resume Glivec at reduced dose of 400 mg. ANC = absolute neutrophil count aoccurring after at least 1 month of treatment

Documents
KEDRION the fourth pillar for the Italian Blood System...KEDRION the fourth pillar for the Italian Blood System Danilo Medica Italy Country Manager Global Blood Donor Challenges -

KEDRION the fourth pillar for the Italian Blood System...KEDRION the fourth pillar for the Italian Blood System Danilo Medica Italy Country Manager Global Blood Donor Challenges -

Documents
Public Assessment Report UKPAR Imatinib 100 mg Film … Pharma (UK) Limited. PAR ... The MHRA decided that the benefits of Imatinib are greater than the risks ... referencing Glivec

Public Assessment Report UKPAR Imatinib 100 mg Film … Pharma (UK) Limited. PAR ... The MHRA decided that the benefits of Imatinib are greater than the risks ... referencing Glivec

Documents
Intellectual property litigations: A case study of Anticancer drug Glivec in India

Intellectual property litigations: A case study of Anticancer drug Glivec in India

Health & Medicine
ANNUAL REPORT - Kedrion · COMPANY PROFILE BY CONVERTING PLASMA INTO MEDICINES, AT KEDRION WE CONTRIBUTE TO MAKING EFFECTIVE AND REAL PEOPLE’S FUNDAMENTAL RIGHTS TO LIFE, FREEDOM

ANNUAL REPORT - Kedrion · COMPANY PROFILE BY CONVERTING PLASMA INTO MEDICINES, AT KEDRION WE CONTRIBUTE TO MAKING EFFECTIVE AND REAL PEOPLE’S FUNDAMENTAL RIGHTS TO LIFE, FREEDOM

Documents
Guida alle attività di convalida dei processi - Guida... · Marco Cerri Responsabile Assicurazione Qualità Stabilimento di Bolognana (Lucca), Kedrion Biopharma SpA. Rosa Chianese

Guida alle attività di convalida dei processi - Guida... · Marco Cerri Responsabile Assicurazione Qualità Stabilimento di Bolognana (Lucca), Kedrion Biopharma SpA. Rosa Chianese

Documents
Code Product Unit - Эколан · 100 mg 10 mg 0.06 mg 50 mg 50 mg 100 mg 0.0068 mg 50 mg 50 mg 10 mg 10 mg 50 mg 10 mg 15 mg 0.002 mg 125 mg 200 mg 1 mL 75 mg 10 mg 0.3 mg 0.004

Code Product Unit - Эколан · 100 mg 10 mg 0.06 mg 50 mg 50 mg 100 mg 0.0068 mg 50 mg 50 mg 10 mg 10 mg 50 mg 10 mg 15 mg 0.002 mg 125 mg 200 mg 1 mL 75 mg 10 mg 0.3 mg 0.004

Documents
GLIVEC vs Union of India

GLIVEC vs Union of India

Documents
VOLUME 33 ISSUE 11 JUNE 2016 - Marketing Research Bureau › wordpress › wp...INOVIO PHARMACEUTICALS KAMADA KEDPLASMA US KEDRION KEDRION BIOPHARMA KYMAB LFB MERUS B.V. NACIMBIO NEW

VOLUME 33 ISSUE 11 JUNE 2016 - Marketing Research Bureau › wordpress › wp...INOVIO PHARMACEUTICALS KAMADA KEDPLASMA US KEDRION KEDRION BIOPHARMA KYMAB LFB MERUS B.V. NACIMBIO NEW

Documents
Glivec, INN-imatinib

Glivec, INN-imatinib

Documents
Glivec®. MECCANISMO DAZIONE DEL GLIVEC Imatinib è un inibitore competitivo di alcune proteine ad attività tirosinochinasica, quali Abl, il recettore per

Glivec®. MECCANISMO DAZIONE DEL GLIVEC Imatinib è un inibitore competitivo di alcune proteine ad attività tirosinochinasica, quali Abl, il recettore per

Documents
Product Information for Glivec · Each hard gelatin capsule contains 50 mg or 100 mg of imatinib ... Capsules: cellulose-microcrystalline, crospovidone, silica colloidal anhydrous,

Product Information for Glivec · Each hard gelatin capsule contains 50 mg or 100 mg of imatinib ... Capsules: cellulose-microcrystalline, crospovidone, silica colloidal anhydrous,

Documents
MG-0100 MG-0101 MG-0102 MG-0103 MG-0075 MG-0076 MG … · 2018. 4. 11. · MG-0025 MG-0026 MG-0027 MG-0010 MG-0011 MG-0012 MG Pinze parallele a 2 griffe - 2-jaw parallel-acting grippers

MG-0100 MG-0101 MG-0102 MG-0103 MG-0075 MG-0076 MG … · 2018. 4. 11. · MG-0025 MG-0026 MG-0027 MG-0010 MG-0011 MG-0012 MG Pinze parallele a 2 griffe - 2-jaw parallel-acting grippers

Documents
ALLEGATO I RIASSUNTO DELLE CARATTERISTICHE DEL …ec.europa.eu/health/documents/community-register/2017/20170508137859/... · Nei pazienti adulti e pediatrici, l'efficacia di Glivec

ALLEGATO I RIASSUNTO DELLE CARATTERISTICHE DEL …ec.europa.eu/health/documents/community-register/2017/20170508137859/... · Nei pazienti adulti e pediatrici, l'efficacia di Glivec

Documents
Glivec - European Medicines Agency · i.e. 50 mg and 100 mg hard capsules, and 100 mg and 400 mg film coated tablets, respectively, ... acetaminophen/ paracetamol and Glivec/Glivec

Glivec - European Medicines Agency · i.e. 50 mg and 100 mg hard capsules, and 100 mg and 400 mg film coated tablets, respectively, ... acetaminophen/ paracetamol and Glivec/Glivec

Documents
GROWTH HORMONE REFERRAL FORM Phone: 833.626.8417 • … · 0.2 mg 0.4 mg 0.6 mg 0.8 mg 1 mg 1.2 mg 1.4 mg 1.6 mg 1.8 mg 2 mg QTY: Refills: Humatrope Powder with Diluent Enroll in

GROWTH HORMONE REFERRAL FORM Phone: 833.626.8417 • … · 0.2 mg 0.4 mg 0.6 mg 0.8 mg 1 mg 1.2 mg 1.4 mg 1.6 mg 1.8 mg 2 mg QTY: Refills: Humatrope Powder with Diluent Enroll in

Documents
23 B -24B [MG 0872 0876 0888 IMG 0881 [MG [MG IMG IMG 0925 ... reading day_new.pdf · 0888 img 0881 [mg [mg img img 0925 [mg [mg [mg 0936 img [mg 0871 [mg 0887 zoo * img [mg [mg img

23 B -24B [MG 0872 0876 0888 IMG 0881 [MG [MG IMG IMG 0925 ... reading day_new.pdf · 0888 img 0881 [mg [mg img img 0925 [mg [mg [mg 0936 img [mg 0871 [mg 0887 zoo * img [mg [mg img

Documents
Product Information for Glivec - Therapeutic Goods ... · Web viewAttachment 1: Product information for AusPAR Glivec Novartis Pharmaceuticals Australia Pty Ltd PM-2011-02797-3-4

Product Information for Glivec - Therapeutic Goods ... · Web viewAttachment 1: Product information for AusPAR Glivec Novartis Pharmaceuticals Australia Pty Ltd PM-2011-02797-3-4

Documents
ANNUAL REPORT - Kedrion 15 ENG_web.pdf · and international legislation; Encouraging all partners and collabo-rators to observe socially responsible practices and contractually obliging

ANNUAL REPORT - Kedrion 15 ENG_web.pdf · and international legislation; Encouraging all partners and collabo-rators to observe socially responsible practices and contractually obliging

Documents
Xeljanz (tofacitinib) - Amgros€¦ · Dosis per administration 5 6 40 200 50 50 162 8 1000 125 750 Dosisdefinition mg mg/kg mg mg mg mg mg mg/kg mg mg mg Forbrugte enheder pr. 52

Xeljanz (tofacitinib) - Amgros€¦ · Dosis per administration 5 6 40 200 50 50 162 8 1000 125 750 Dosisdefinition mg mg/kg mg mg mg mg mg mg/kg mg mg mg Forbrugte enheder pr. 52

Documents
ANNUAL REPORT 2020 - Kedrion

ANNUAL REPORT 2020 - Kedrion

Documents
The Burning Platform ¬ Sorafenib (Nexavar®) € 46,000 ¬ Trastuzumab (Herceptin®) € 38,200 ¬ Bevacizumab (Avastin®) € 37,200 ¬ Imatinib (Glivec 400®) € 36,400 ¬ Erlotinib

The Burning Platform ¬ Sorafenib (Nexavar®) € 46,000 ¬ Trastuzumab (Herceptin®) € 38,200 ¬ Bevacizumab (Avastin®) € 37,200 ¬ Imatinib (Glivec 400®) € 36,400 ¬ Erlotinib

Documents
Statin Tolerability: Overcoming the Treatment Gap...rosuvastatin simvastatin 10 mg 20 mg 40 mg 80 mg 10 mg 20 mg 40 mg 80 mg 20 mg 40 mg 80 mg Proteinuria ≥ 2+ (%) 0.6% 2% 4% 0.4%

Statin Tolerability: Overcoming the Treatment Gap...rosuvastatin simvastatin 10 mg 20 mg 40 mg 80 mg 10 mg 20 mg 40 mg 80 mg 20 mg 40 mg 80 mg Proteinuria ≥ 2+ (%) 0.6% 2% 4% 0.4%

Documents
Workshop 2015 - Kedrion

Workshop 2015 - Kedrion

Presentations & Public Speaking
SERVIZIO PIANIFICAZIONE URBANISTICA · SERVIZIO PIANIFICAZIONE URBANISTICA 3 Osservazione n. 3 – Prot. n. 8287 del 19/11/2018 Richiedente: Sig. Simone Boaglio (Procuratore Kedrion

SERVIZIO PIANIFICAZIONE URBANISTICA · SERVIZIO PIANIFICAZIONE URBANISTICA 3 Osservazione n. 3 – Prot. n. 8287 del 19/11/2018 Richiedente: Sig. Simone Boaglio (Procuratore Kedrion

Documents